cefotaxime syn S-oxide

syn S-oxide derivative of cefotaxime; structure in first source; RN given refers to (5S-(5alpha,6beta,7alpha(Z)))-isomer

Also Known As:

HR 109; HR-109; cefotaxime syn S-oxide, (5R-(5alpha,6alpha,7beta(Z)))-isomer; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, 5-oxide, (5S-(5alpha,6beta,7alpha(Z)))-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Vasovagal Syncope 01/01/1992 - "In patients with vasovagal syncope, the heart rate (HR) and the mean blood pressure (mBP) were higher at the time of supine positioning than at the time of syncope (HR: 109 +/- 16-->88 +/- 16 bpm, p < 0.05) (mBP: 86 +/- 5-->53 +/- 6 mmHg, p < 0.01). "
2.	Syncope (Fainting) 01/01/1992 - "In patients with vasovagal syncope, the heart rate (HR) and the mean blood pressure (mBP) were higher at the time of supine positioning than at the time of syncope (HR: 109 +/- 16-->88 +/- 16 bpm, p < 0.05) (mBP: 86 +/- 5-->53 +/- 6 mmHg, p < 0.01). "
3.	Shock 08/01/1985 - "Dopamine infusion at shock level resulted in an increase of the following variables (% of baseline value): MAP (69%), HR (109%), CI (138%) and SVI (129%). "

Related Drugs and Biologics

1.	Dopamine (Intropin)